First-line treatment selection in follicular lymphoma is closely tied to tumor stage, disease burden, and patient-specific ...

The subcutaneous formulation of the bispecific antibody reduces treatment time to 1 minute vs 2-4 hours with IV infusion.

The FDA granted accelerated approval to Lunsumio VELO for adults with relapsed/refractory follicular lymphoma after two or ...

Lymphoma is a type of blood cancer that targets the lymphatic system. This type of cancer impacts the cells that are a part of one's immune system, according to the American Cancer Society. There are ...

Studies presented at the ASH Annual Meeting 2025 highlighted a novel prognostic approach and emerging treatment strategies in lymphoma.

Fred Hutch researchers pioneered bone marrow transplantation, one of the most significant advances in treating lymphoma, leukemia and other blood cancers. We continue to improve bone marrow and blood ...

Join Dr Krish Patel and discover groundbreaking updates in lymphoma and CLL treatments, including innovative therapies and ...

Hodgkin lymphoma, also called Hodgkin disease, is one of the two main kinds of lymphoma. (The other is non-Hodgkin lymphoma.) Most people with Hodgkin lymphoma have what is called the “classical” type ...

People aged 80 and older with a common type of lymphoma can take a half-dose of chemotherapy and be cured or significantly extend their survivorship with fewer toxic side effects, a new study shows.

Austin, July 18, 2025 (GLOBE NEWSWIRE) -- Lymphoma Treatment Market Size & Growth Analysis: According to SNS Insider, the global Lymphoma Treatment Market was valued at USD 7.01 billion in 2023 and is ...